Publication:
Imidacloprid poisoning case series: potential for liver injury

dc.contributor.authorC. Sriaphaen_US
dc.contributor.authorS. Trakulsrichaien_US
dc.contributor.authorP. Intaraprasongen_US
dc.contributor.authorS. Wongvisawakornen_US
dc.contributor.authorA. Tongpooen_US
dc.contributor.authorJ. Schimmelen_US
dc.contributor.authorW. Wananukulen_US
dc.contributor.otherRocky Mountain Poison and Drug Centeren_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2020-01-27T03:38:43Z
dc.date.available2020-01-27T03:38:43Z
dc.date.issued2020-02-01en_US
dc.description.abstract© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Introduction: Imidacloprid is a commonly used neonicotinoid insecticide in Thailand. Limited reports suggest it may be associated with liver injury. Case series: A retrospective poison center case series identified 128 cases of imidacloprid ingestion from 2010–2016, of which four developed liver injury. Results: Three patients ingested soluble liquid concentrates and one ingested water-dispersible granules of imidacloprid. The estimated doses of ingestion ranged from 2–35 g. One patient developed cholestatic liver injury, two developed hepatocellular liver injury, and the remaining patient, who ingested the highest dose, developed a mixed pattern of liver injury. Median onset of liver injury was 5.5 days. Discussion: In prior case reports and animal studies, these cases suggest imidacloprid toxicity is associated with liver injury that may be delayed. This is consistent with our finding. The cases also demonstrated a possible dose-response relationship of imidacloprid ingestion with severity and type of liver injury. All findings suggested that imidacloprid might contribute to liver injury. Conclusion: We report four cases of liver injury, which are possibly related to ingestion of imidacloprid. In management, consideration should be given to repeating liver tests as an outpatient if initial tests are normal, with counseling on the possibility of delayed liver injury.en_US
dc.identifier.citationClinical Toxicology. Vol.58, No.2 (2020), 136-138en_US
dc.identifier.doi10.1080/15563650.2019.1616091en_US
dc.identifier.issn15569519en_US
dc.identifier.issn15563650en_US
dc.identifier.other2-s2.0-85065984127en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/49684
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065984127&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleImidacloprid poisoning case series: potential for liver injuryen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065984127&origin=inwarden_US

Files

Collections